Cargando…
Proton pump inhibitors and myocardial infarction: an application of active comparators in a self-controlled case series
BACKGROUND: Previous studies investigating potential cardiovascular adverse events of acid-suppressing drugs are susceptible to protopathic bias and confounding. We aimed to investigate the association between short-term risk of myocardial infarction (MI) and proton pump inhibitors (PPIs) using a se...
Autores principales: | Chui, Celine S L, Cheung, Ka Shing, Brown, Jeremy P, Douglas, Ian J, Wong, Ian C K, Chan, Esther W, Wong, Angel Y S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244046/ https://www.ncbi.nlm.nih.gov/pubmed/36259933 http://dx.doi.org/10.1093/ije/dyac196 |
Ejemplares similares
-
Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
por: Shah, Nigam H., et al.
Publicado: (2015) -
Correction to: Proton pump inhibitors and myocardial infarction: an application of active comparators in a self-controlled case series
Publicado: (2022) -
Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence
por: Cheung, Ka Shing, et al.
Publicado: (2019) -
Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after Helicobacter pylori eradication
por: Cheung, Ka Shing, et al.
Publicado: (2018) -
Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
por: Lee, Yong Kang, et al.
Publicado: (2023)